Akcea Therapeutics names new senior vice president of global medical affairs
21 July 2020 -

It was reported on Monday that US-based Akcea Therapeutics Inc (NASDAQ: AKCA) has named Christophe Hotermans, MD, PhD as its new senior vice president of global medical affairs.

In the new role, Dr Hotermans is to lead and evolve the implementation of medical strategies, activities and operations globally in collaboration with executive management.

Dr Hotermans has over 20 years of experience with more than 12 years in the biotechnology industry. Prior to joining the company, Dr Hotermans has served at Biogen in various roles, with the most recent being vice president and head of United States medical. He has also served as chief of the neurology clinic at the University of Liege in Belgium.